Lars Krogvold

3.1k total citations
48 papers, 1.8k citations indexed

About

Lars Krogvold is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lars Krogvold has authored 48 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 32 papers in Surgery and 27 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lars Krogvold's work include Diabetes and associated disorders (37 papers), Pancreatic function and diabetes (32 papers) and Diabetes Management and Research (24 papers). Lars Krogvold is often cited by papers focused on Diabetes and associated disorders (37 papers), Pancreatic function and diabetes (32 papers) and Diabetes Management and Research (24 papers). Lars Krogvold collaborates with scholars based in Norway, Sweden and United States. Lars Krogvold's co-authors include Knut Dahl‐Jørgensen, Noel G. Morgan, Sarah J. Richardson, Pia Leete, Oskar Skog, Olle Korsgren, Kristian F. Hanssen, Bjørn Edwin, Trond Buanes and Alan K. Foulis and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lars Krogvold

45 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Krogvold Norway 23 1.3k 1.1k 869 404 265 48 1.8k
Dongmei Miao United States 29 2.6k 1.9× 1.9k 1.8× 1.7k 2.0× 938 2.3× 200 0.8× 75 3.3k
Akira Kasuga Japan 20 900 0.7× 600 0.5× 595 0.7× 299 0.7× 183 0.7× 44 1.3k
Laura Nigi Italy 19 305 0.2× 341 0.3× 278 0.3× 108 0.3× 411 1.6× 40 1.1k
Songyan Deng United States 19 446 0.3× 460 0.4× 261 0.3× 554 1.4× 195 0.7× 24 1.3k
James A. Pearson United Kingdom 15 361 0.3× 215 0.2× 175 0.2× 294 0.7× 341 1.3× 37 833
Mia J. Smith United States 18 336 0.3× 213 0.2× 207 0.2× 469 1.2× 215 0.8× 37 1.0k
Eva Lavant Sweden 7 658 0.5× 444 0.4× 392 0.5× 308 0.8× 110 0.4× 9 914
Piotr Fichna Poland 17 336 0.3× 186 0.2× 352 0.4× 168 0.4× 246 0.9× 71 1.0k
Hisafumi Yasuda Japan 17 374 0.3× 313 0.3× 203 0.2× 243 0.6× 188 0.7× 49 764
Brian Wilson United States 7 573 0.4× 226 0.2× 162 0.2× 983 2.4× 66 0.2× 13 1.3k

Countries citing papers authored by Lars Krogvold

Since Specialization
Citations

This map shows the geographic impact of Lars Krogvold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Krogvold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Krogvold more than expected).

Fields of papers citing papers by Lars Krogvold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Krogvold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Krogvold. The network helps show where Lars Krogvold may publish in the future.

Co-authorship network of co-authors of Lars Krogvold

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Krogvold. A scholar is included among the top collaborators of Lars Krogvold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Krogvold. Lars Krogvold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buschard, Karsten, Lars Krogvold, Flemming Pociot, et al.. (2025). TLR5 influences the development of type 1 diabetes. BMJ Open Diabetes Research & Care. 13(5). e005111–e005111.
2.
Krogvold, Lars, Nina Lindblom, Jacob Westman, et al.. (2025). Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial. Diabetes Care. 48(3). 481–488. 2 indexed citations
3.
Buschard, Karsten, et al.. (2023). Type 1 diabetes could begin with alterations in innate anti‐viral immunity, which are already at this stage associated with HLA risk haplotypes. Diabetes/Metabolism Research and Reviews. 39(7). e3678–e3678. 1 indexed citations
4.
Krogvold, Lars, et al.. (2023). A Toddler with Systemic Contact Dermatitis Caused by Diabetes Devices. SHILAP Revista de lepidopterología. 3(4). e234–e234. 3 indexed citations
5.
Svalastoga, Pernille, Janne Molnes, Bente B. Johansson, et al.. (2023). Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes. Diabetologia. 66(12). 2226–2237. 1 indexed citations
6.
Krogvold, Lars, Angelo Genoni, Daniela Campani, et al.. (2022). Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study. Diabetologia. 65(12). 2108–2120. 25 indexed citations
7.
Krogvold, Lars, Pia Leete, Mark A. Russell, et al.. (2022). Detection of Antiviral Tissue Responses and Increased Cell Stress in the Pancreatic Islets of Newly Diagnosed Type 1 Diabetes Patients: Results From the DiViD Study. Frontiers in Endocrinology. 13. 881997–881997. 11 indexed citations
8.
Välikangas, Tommi, Maria K. Jaakkola, Lars Krogvold, et al.. (2022). Pancreas Whole Tissue Transcriptomics Highlights the Role of the Exocrine Pancreas in Patients With Recently Diagnosed Type 1 Diabetes. Frontiers in Endocrinology. 13. 861985–861985. 1 indexed citations
9.
10.
Haupt‐Jorgensen, Martin, Lars Krogvold, Simranjeet Kaur, et al.. (2021). Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity. Diabetologia. 64(8). 1805–1815. 17 indexed citations
11.
Nigi, Laura, Noemi Brusco, Giuseppina Emanuela Grieco, et al.. (2020). Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes. Frontiers in Endocrinology. 11. 630–630. 24 indexed citations
12.
Wiberg, Anna, Enida Kuric, Lars Krogvold, et al.. (2019). Characterisation of the endocrine pancreas in type 1 diabetes: islet size is maintained but islet number is markedly reduced. The Journal of Pathology Clinical Research. 5(4). 248–255. 36 indexed citations
13.
Kuric, Enida, Lars Krogvold, Kristian F. Hanssen, et al.. (2018). No Evidence for Presence of Mucosal-Associated Invariant T Cells in the Insulitic Lesions in Patients Recently Diagnosed with Type 1 Diabetes. American Journal Of Pathology. 188(8). 1744–1748. 17 indexed citations
14.
Kuric, Enida, Lars Krogvold, Bjørn Edwin, et al.. (2017). Demonstration of Tissue Resident Memory CD8 T Cells in Insulitic Lesions in Adult Patients with Recent-Onset Type 1 Diabetes. American Journal Of Pathology. 187(3). 581–588. 66 indexed citations
15.
Brand, Frank, Anna‐Carina Weiss, Martin Kreuzer, et al.. (2017). Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations. Human Molecular Genetics. 26(9). 1716–1731. 28 indexed citations
16.
Krogvold, Lars, Shebani Farik, Satya Amirapu, et al.. (2017). An immunohistochemical study of nitrotyrosine expression in pancreatic islets of cases with increasing duration of type 1 diabetes and without diabetes. Histochemistry and Cell Biology. 147(5). 605–623. 2 indexed citations
17.
Lundberg, Marcus, Lars Krogvold, Enida Kuric, Knut Dahl‐Jørgensen, & Oskar Skog. (2016). Expression of Interferon-Stimulated Genes in Insulitic Pancreatic Islets of Patients Recently Diagnosed With Type 1 Diabetes. Diabetes. 65(10). 3104–3110. 97 indexed citations
18.
Krogvold, Lars, Anna Wiberg, Bjørn Edwin, et al.. (2015). Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes. Diabetologia. 59(3). 492–501. 68 indexed citations
19.
Krogvold, Lars, Anna Bjerre, Damien Brackman, et al.. (2011). Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 19(1). 44–44. 13 indexed citations
20.
Tveten, Yngvar, et al.. (1994). Restriction endonuclease analysis of adenovirus type 3 isolated in Norway from 1970 to 1991. Apmis. 102(1-6). 215–218. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongmei Miao Breakdown of academic impact, for papers by Akira Kasuga Breakdown of academic impact, for papers by Laura Nigi Breakdown of academic impact, for papers by Songyan Deng Breakdown of academic impact, for papers by James A. Pearson Breakdown of academic impact, for papers by Mia J. Smith Breakdown of academic impact, for papers by Eva Lavant Breakdown of academic impact, for papers by Piotr Fichna Breakdown of academic impact, for papers by Hisafumi Yasuda Breakdown of academic impact, for papers by Brian Wilson
Rankless by CCL
2026